| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000020066 |
| Receipt No. | R000023177 |
| Official scientific title of the study | The observational study on the relations of small bowel endoscopic findings and variability of fecal markers in Crohn's disease |
| Date of disclosure of the study information | 2015/12/04 |
| Last modified on | 2018/06/07 (Ver. 11) |
| Basic information | ||
| Official scientific title of the study | The observational study on the relations of small bowel endoscopic findings and variability of fecal markers in Crohn's disease | |
| Title of the study (Brief title) | The observational study on the relations of small bowel endoscopic findings and fecal markers in Crohn's disease | |
| Region |
|
|
| Condition | ||
| Condition | Crohn's disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the usefulness of endoscopic findings and variability of fecal calprotectin in Crohn's disease |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To compare fecal calprotectin with or without small-intestinal and colorectal lesion |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patient aged 20 and more who planned double-ballon endoscopy for the suspected crohn's disease | |||
| Key exclusion criteria | 1)Patients with acute abdomen
2)Patients with severe acute inflammation 3)pregnant patients 4)Patients in a very bad general condition 5)Patients having severe blood clotting defect 6)Patients who have participated in same clinical trials 7)Patients, the investigator (or the subinvestigator) considers, inappropriate for entry into the trial |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Watanabe Osamu |
| Organization | Nagoya University Hospital |
| Division name | Department of Gastroenterology and Hepatology |
| Address | 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan |
| TEL | 052-744-2172 |
| osa-wata@med.nagoya-u.ac.jp | |
| Public contact | |
| Name of contact person | Masanao Nakamura |
| Organization | Nagoya University Hospital |
| Division name | Department of Gastroenterology and Hepatology |
| Address | 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan |
| TEL | 052-744-2172 |
| Homepage URL | |
| makamura@med.nagoya-u.ac.jp | |
| Sponsor | |
| Institute | Nagoya University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nagoya University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Measurements;
Endoscopic findings/blood exam(red blood cells, white blood cells, hemogram, platelets, amylase, C-reactive protein, hepatobiliary system enzyme, lactase dehydrogenase, blood urea nitrogen, creatinine, total protein, albumin, erythrocyte sedimentation rate)/fecal calprotectin,immunological fecal occult blood test/IOIBD(International Organization for the Study of Inflammatory Bowel Disease)/CDAI(Crohn's Disease Activity Index)/histopathological findings |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023177 |